Cognitive disengagement syndrome: A construct at the crossroads
- PMID: 40146579
- PMCID: PMC12289433
- DOI: 10.1037/amp0001517
Cognitive disengagement syndrome: A construct at the crossroads
Abstract
Initially described in the mid-1980s, cognitive disengagement syndrome (CDS; previously termed sluggish cognitive tempo) is a set of symptoms comprising excessive daydreaming, mental confusion, and hypoactivity that is distinct from attention-deficit/hyperactivity disorder and other psychopathology dimensions and independently associated with functional outcomes. This article provides a broad overview of the history of the CDS construct, its terminology, and the current state of the science. Although there has been a marked upsurge in research on CDS, including psychometrically rigorous assessment tools and an emerging pattern of findings across numerous domains of functioning, the existing literature base also points to the importance of marshaling an ambitious research agenda that can guide CDS into its next era. Ten key research domains and open questions are highlighted, including (1) developmental course of CDS across the lifespan, (2) mechanisms linking CDS to functional outcomes and impairment, (3) importance of gathering normative data, (4) clarifying CDS and unidimensional or multidimensional, (5) etiologies of CDS, (6) neurobiology and psychophysiology of CDS, (7) CDS as a transdiagnostic trait, (8) understanding individuals with elevated CDS, (9) promoting participatory approaches and valuing lived experience, and (10) the role of CDS for intervention. Implications of this research for possible conceptualizations of CDS as a distinct disorder, diagnostic specifier, or transdiagnostic dimension are discussed. The road ahead will require increased collaboration, creativity, and rigor to build theory, and, ultimately, support the well-being of individuals with this syndrome. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
References
-
- Adler LA, Leon TL, Sardoff TM, Krone B, Faraone SV, Silverstein MJ, & Newcorn JH (2021). A placebo-controlled trial of lisdexamfetamine in the treatment of comorbid sluggish cognitive tempo and adult ADHD. J Clin Psychiatry, 82(4), 34965. - PubMed
-
- Aldhous P (2014, September 29, 2014). The daydream disorder: Is sluggish cognitive tempo a disease or disease mongering? Slate.
-
- American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders, Third Edition (DSM-III ed.). American Psychiatric Association.
-
- American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders, Third Edition - Revised (DSM-III-R ed.). American Psychiatric Association.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources